Atovaquone (Prasco Laboratories)


Welcome to the PulseAid listing for the Atovaquone drug offered from Prasco Laboratories. This Antimalarial [EPC],Antiprotozoal [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Prasco Laboratories
NON-PROPRIETARY NAME: atovaquone
SUBSTANCE NAME: ATOVAQUONE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antimalarial [EPC],Antiprotozoal [EPC]
ROUTE: ORAL
DOSAGE FORM: SUSPENSION
MARKETING CATEGORY NAME: NDA AUTHORIZED GENERIC
START MARKETING DATE: 2014-03-20
END MARKETING DATE: 0000-00-00


Atovaquone HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAtovaquone from Prasco Laboratories
LABELER NAME: Prasco Laboratories
DEA SCHEDULE:
ACTIVE STRENGTH: 750(mg/5mL)
START MARKETING DATE: 2014-03-20
END MARKETING DATE: 0000-00-00
PRODUCT ID: 66993-062_13e51f0c-865e-4007-95d8-ac7eb9da8740
PRODUCT NDC: 66993-062
APPLICATION NUMBER: NDA020500

Other ATOVAQUONE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Amneal Pharmaceuticals LLCATOVAQUONE
GlaxoSmithKline LLCMEPRON
Prasco LaboratoriesAtovaquone